Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endoscopic Surgery Effectively Relieves Sinusitis Symptoms

By HospiMedica International staff writers
Posted on 20 May 2009
Functional endoscopic sinus surgery (FESS) can significantly relieve symptoms of chronic rhinosinusitis (inflammation of the sinus cavities), according to a new study.

Researchers at Georgetown University Medical Center (GUMC, Washington, DC, USA) and St. More...
Louis University School of Medicine (MI, USA) conducted a meta-analysis of symptom relief following sinus surgery, examining 21 different published studies which included a total of 2,070 patients, and analyzed improvement for each symptom usually associated with chronic sinusitis, including nasal obstruction, facial pain, postnasal discharge, headaches, and impaired smell. The researchers assessed symptom relief using two different measures; a measurement called "effect size", where any effect greater than 0.8 is considered a large effect; and a second measurement, which is less accurate but more commonly used, that compares the percent of improvement in symptoms after surgery compared to the situation before surgery.

The researchers found that with a 1.73 effect size, nasal obstruction improved the most, followed by postnasal discharge (1.19), facial pain (1.13), headache relief (.98) and improvement in smell (.97). Percentage improvements pre- and post-surgery were 61% in facial pain, 59% in nasal obstruction, 53% in headache, 49% in smell, and 47% in postnasal discharge. The researchers also found that improvements do not decrease over time, as some smaller studies had suggested. The study was published in the In the May 2009 issue of Otolaryngology Head Neck Surgery.

"Reports of relative symptom relief vary across studies, so it was important to pool the study results. We wanted to know not only if symptoms improve overall, but if they improve to a similar degree, and if these benefits last,” said lead author Alexander Chester, M.D., a physician and clinical professor at GUMC. "Our findings offer reassurance that, with minor exceptions, individual symptoms usually improve substantially and similarly following surgery.”

FESS is the mainstay in the surgical treatment of sinusitis and nasal polyposis, including fungal sinusitis. The procedure uses nasal endoscopes (with Hopkins rod lens telescopes) to minimize cutting and trauma to the skin. The endoscopes have diameters of 4 mm and 2.7 mm and come in varying angles of vision, providing good illumination of the inside of the head. There are four sinuses dealt with by means of this surgery: The frontal sinus with frontal recess dissection, the maxillary by uncinectomy and antrostomy, the anterior and posterior ethmoids, which require careful dissection to the skullbase and orbital lamina, and finally the sphenoid sinus which is managed via a sphenoidotomy. Extreme care is required due to the paranasal sinus' proximity to the orbits, brain, internal carotid arteries, and optic nerves.

Related Links:

Georgetown University Medical Center
St. Louis University School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.